Bruker Corp (BRKR)
59.35
+0.06
(+0.10%)
USD |
NASDAQ |
Nov 04, 16:00
58.00
-1.35
(-2.27%)
After-Hours: 20:00
Bruker Debt to Equity Ratio: 1.206 for June 30, 2024
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
Date | Value |
---|---|
June 30, 2024 | 1.206 |
March 31, 2024 | 0.974 |
December 31, 2023 | 0.9305 |
September 30, 2023 | 1.009 |
June 30, 2023 | 1.010 |
March 31, 2023 | 1.041 |
December 31, 2022 | 1.095 |
September 30, 2022 | 1.231 |
June 30, 2022 | 1.221 |
March 31, 2022 | 1.196 |
December 31, 2021 | 1.246 |
September 30, 2021 | 0.7689 |
June 30, 2021 | 0.8276 |
March 31, 2021 | 0.8517 |
December 31, 2020 | 0.8786 |
September 30, 2020 | 0.8717 |
June 30, 2020 | 1.142 |
March 31, 2020 | 1.104 |
December 31, 2019 | 0.8969 |
September 30, 2019 | 0.6138 |
June 30, 2019 | 0.5741 |
March 31, 2019 | 0.3664 |
December 31, 2018 | 0.3804 |
September 30, 2018 | 0.2945 |
June 30, 2018 | 0.2841 |
Date | Value |
---|---|
March 31, 2018 | 0.2823 |
December 31, 2017 | 0.5729 |
September 30, 2017 | 0.6566 |
June 30, 2017 | 0.5701 |
March 31, 2017 | 0.531 |
December 31, 2016 | 0.5998 |
September 30, 2016 | 0.5259 |
June 30, 2016 | 0.5171 |
March 31, 2016 | 0.4304 |
December 31, 2015 | 0.3661 |
September 30, 2015 | 0.4885 |
June 30, 2015 | 0.4792 |
March 31, 2015 | 0.4954 |
December 31, 2014 | 0.4635 |
September 30, 2014 | 0.4399 |
June 30, 2014 | 0.4041 |
March 31, 2014 | 0.4113 |
December 31, 2013 | 0.4196 |
September 30, 2013 | 0.4577 |
June 30, 2013 | 0.4681 |
March 31, 2013 | 0.4884 |
December 31, 2012 | 0.4772 |
September 30, 2012 | 0.4864 |
June 30, 2012 | 0.5024 |
March 31, 2012 | 0.4853 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
0.7689
Minimum
Sep 2021
1.246
Maximum
Dec 2021
1.026
Average
1.010
Median
Jun 2023
Debt to Equity Ratio Benchmarks
Bio-Rad Laboratories Inc | 0.1604 |
Azenta Inc | 0.00 |
Harvard Bioscience Inc | 0.5306 |
Bionano Genomics Inc | 0.241 |
Akoya Biosciences Inc | 3.402 |
Debt to Equity Ratio Related Metrics
Total Assets (Quarterly) | 5.903B |
Total Liabilities (Quarterly) | 4.078B |
Shareholders Equity (Quarterly) | 1.789B |
Current Ratio | 1.650 |
Net Debt Paydown Yield | -1.92% |